| abstract |
The present invention provides at least one novel human GLP-1 mimetic or specific moiety or variant, GLP-1 mimetic or particular moiety comprising an isolated nucleic acid encoding at least one GLP-1 mimetic or particular moiety or variant. Or variants, vectors, host cells, transgenic animals or plants, and methods of making and using the same, including therapeutic compositions, methods and devices. |